INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
MA
Corporate insider

Mahon Paul A

EVP & GENERAL COUNSELCIK 0001231589

EDGAR filingsOpen in network
Disclosed transactions11
Buys / sells0 / 9
Max Insider Score19
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$312K
526 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    UNITED THERAPEUTICS CorpOfficer · Form 144 · Nov 4, 2026
16
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL
$698K
1,174 sh
Nov 5, 2026
Nov 5, 2026
traded Nov 5, 2026
+0d
SEC FORM 4

Evidence

16
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$749K
1,256 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC FORM 4

Evidence

10
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$47K
78 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC FORM 4

Evidence

16
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$409K
683 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC FORM 4

Evidence

16
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$605K
1,010 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC FORM 4

Evidence

19
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.23M
2,039 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC FORM 4

Evidence

13
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$241K
401 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC FORM 4

Evidence

16
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$683K
1,133 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC FORM 4

Evidence

11
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
8,300 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC FORM 4

Evidence

12
MA
Mahon Paul AEVP & GENERAL COUNSEL
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.21M
8,300 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC FORM 4

Evidence